Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
DNA and Cell Biology
|
September 1, 2009
Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
Jaqueline J Muniz, Tatiane C Izidoro-Toledo, Ingrid F Metzger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 4, 2016
Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers
Andrea R Masters, Brandon T Gufford, Jessica Bo Li Lu, et al.
Antimicrobial Agents and Chemotherapy
|
November 2, 2016
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition
Jason D Robarge, Ingrid F Metzger, Jessica Lu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 24, 2010
Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia
Valeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Thrombosis Research
|
March 1, 2005
eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population
Sabrina Nagassaki, Ingrid F Metzger, Debora C Souza-Costa, et al.
Free Radical Biology & Medicine
|
September 12, 2006
eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite
Sabrina Nagassaki, Jonas T C Sertório, Ingrid F Metzger, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 25, 2008
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
Valeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Clinical Pharmacology and Therapeutics
|
August 11, 2020
Circulating miRNAs as Biomarkers for CYP2B6 Enzyme Activity
Joseph Ipe, Rudong Li, Ingrid F Metzger, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 24, 2025
A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe
Kimberly S Collins, Blessed W Aruldhas, Ingrid F Metzger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 7, 2022
<b> </b>
Brandon T Gufford, Ingrid F Metzger, Nadia O Bamfo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
DNA and Cell Biology
|
September 1, 2009
Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
Jaqueline J Muniz, Tatiane C Izidoro-Toledo, Ingrid F Metzger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 4, 2016
Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers
Andrea R Masters, Brandon T Gufford, Jessica Bo Li Lu, et al.
Antimicrobial Agents and Chemotherapy
|
November 2, 2016
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition
Jason D Robarge, Ingrid F Metzger, Jessica Lu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
June 24, 2010
Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia
Valeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Thrombosis Research
|
March 1, 2005
eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population
Sabrina Nagassaki, Ingrid F Metzger, Debora C Souza-Costa, et al.
Free Radical Biology & Medicine
|
September 12, 2006
eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite
Sabrina Nagassaki, Jonas T C Sertório, Ingrid F Metzger, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 25, 2008
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia
Valeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Clinical Pharmacology and Therapeutics
|
August 11, 2020
Circulating miRNAs as Biomarkers for CYP2B6 Enzyme Activity
Joseph Ipe, Rudong Li, Ingrid F Metzger, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 24, 2025
A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe
Kimberly S Collins, Blessed W Aruldhas, Ingrid F Metzger, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 7, 2022
<b> </b>
Brandon T Gufford, Ingrid F Metzger, Nadia O Bamfo, et al.
Page
of 4